CNS Pharmaceuticals Inc. share price logo

CNS Pharmaceuticals Inc.

NASDAQ: CNSP

$4.94

+0.26

(+5.56%)

as on

CNS Pharmaceuticals Inc. Stock Performance

as on July 3, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $4.66
    $5.00
    downward going graph

    5.67%

    Downside

    1.21%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.90
    $12.36
    downward going graph

    61.54%

    Downside

    150.20%

    Upside

    downward going graph

CNS Pharmaceuticals Inc. share price movements today

Previous Close
$4.68
Open
$4.66
Volume
77.3K
Day's Low - High
$4.66 - $5.00
52 Week Low - High
$1.90 - $12.36

CNS Pharmaceuticals Inc. Historical Returns

1 Month Return
-4.88 %
3 Month Return
+ 107.08 %
1 Year Return
-58.51 %
3 Year Return
-99.99 %
5 Year Return
-100 %

CNS Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Check CNS Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.0M

EPS (TTM)

-1.65

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-16.6M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-298.64%

CNS Pharmaceuticals Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of CNS Pharmaceuticals Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
CNS Pharmaceuticals Inc. image
CNS Pharmaceuticals Inc.
SELL$7.0M-100%NA0.00%NA
Revolution Medicines Inc. image
Revolution Medicines Inc.
BUY$39.8B472.9%NA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$40.2B75.97%75.8312.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$126.1B148.33%29.535.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$65.4B7.04%15.2229.65%0.5700000000000001%

Stock Returns calculator for CNS Pharmaceuticals Inc. Stock including INR - Dollar returns

The CNS Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

CNS Pharmaceuticals Inc. investment value today

Current value as on today

₹48,789

Returns

-₹51,211

(-51.21%)

Returns from CNS Pharmaceuticals Inc. Stock

-₹56,206 (-56.21%)

Dollar Impact

₹4,994 (+4.99%)

Analyst Recommendation on CNS Pharmaceuticals Inc. Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for CNS Pharmaceuticals Inc.. Average target price of $10

CNS Pharmaceuticals Inc. Share Price Target

Get share price movements and forecasts by analysts on CNS Pharmaceuticals Inc..

What analysts predicted

50.6%UPSIDE

Target Price

$10

Current Price

$4.94

Analyzed by

6 Analysts

Target

$10.00

CNS Pharmaceuticals Inc. target price $10, a slight upside of 50.6% compared to current price of $4.94. According to 6 analysts rating.

Indian Investors' Interest in CNS Pharmaceuticals Inc. Stock

Search interest for CNS Pharmaceuticals Inc. Stock has decreased by -86% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-86% versus previous 30 day period

CNS Pharmaceuticals Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
0
-
-
0
0
-
-
-
-
Gross Profit
-
0
0
0
0
0
0
0
0
0
Operating Income
-5
-3
-2
-5
-3
-4
-2
-3
-5
-4
EBITDA
-
-3
-2
-5
-3
-4
-2
-3
-5
-4
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-5
-3
-2
-5
-3
-4
-2
-3
-5
-4
Income Tax Expense
-
0
0
-
-
-
-
-
-
-
Net Income
-5
-3
-2
-5
-3
-4
-2
-3
-5
-4
Net Profit Margin
0.00%
-55717.51%
0.00%
0.00%
-101158.15%
-136984.71%
0.00%
0.00%
0.00%
0.00%

CNS Pharmaceuticals Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
-
0
0
0
0
0
0
-
Operating Income
0
-3
-9
-14
-14
-18
-14
-15
EBITDA
-6
-3
-9
-14
-15
-18
-14
-15
Interest Expense
0
0
0
0
0
0
0
0
Depreciation
-
0
0
0
0
0
0
0
Income Before Tax
-7
-3
-9
-14
-15
-18
-14
-15
Income Tax Expense
0
0
0
0
0
0
-
-
Net Income
-7
-3
-9
-14
-15
-18
-14
-15
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

CNS Pharmaceuticals Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-3
-2
-5
-3
-4
-2
-3
-5
-4
Operating Cash Flow
-3
-1
-6
-5
-3
-5
-2
-3
-4
Investing Cash Flow
0
-
-
0
0
-
-
0
0
Financing Cash Flow
3
2
12
4
9
4
0
0
0
Change in Cash
0
0
5
0
6
0
-2
-2
-4

CNS Pharmaceuticals Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-7
-3
-9
-14
-15
-18
-14
-15
Operating Cash Flow
0
-3
-7
-13
-10
-14
-17
-13
Investing Cash Flow
0
0
0
0
0
0
0
0
Financing Cash Flow
1
10
14
4
15
4
23
14
Change in Cash
0
6
6
-9
5
-9
5
0

Global Institutional Holdings in CNS Pharmaceuticals Inc.

Funds
Holdings
Stonepine Capital Management Llc
4.17%
Ground Swell Capital, LLC
0%
Ikarian Capital, LLC
3.14%
Integrated Wealth Concepts LLC
0%
DRW Securities, LLC
0%
See all

Insights on CNS Pharmaceuticals Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, CNSP stock has moved up by 12.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 404.2% return, outperforming this stock by 462.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 601.0% return, outperforming this stock by 701.0%

About CNS Pharmaceuticals Inc.

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of therapies for neurology and oncology diseases in the United States. It develops TPI 287, an investigational chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma, metastatic breast cancer with brain metastases, non-small cell lung cancer, castration-resistant prostate cancer, and neuroblastoma; and Berubicin, an investigational anthracycline chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma and brain tumors. The company was incorporated in 2017 and is headquartered in Houston, Texas.
OrganisationCNS Pharmaceuticals Inc.
Headquarters2100 West Loop South, Houston, TX, United States, 77027
IndustryBiotechnology
CEOMr. Rami Levin M.B.A.
E-voting on sharesClick here to vote

Key Management of CNS Pharmaceuticals Inc.

Name

Title

Mr. Christopher S. Downs CPA, CTP, FP&A

Senior Vice President of Finance

Mr. Rami Levin M.B.A.

President, CEO & Director

Mr. Steve O'Loughlin M.B.A.

Chief Financial Officer

Mr. Eric Faulkner M.B.A., M.Sc.

Chief Technology Officer

Mr. Dylan Wenke M.B.A.

Chief Business Officer

Dr. E. Lynne Kelley F.A.C.S., M.D.

Chief Medical Officer

FAQs

What is CNS Pharmaceuticals Inc. share price today?

CNS Pharmaceuticals Inc. share price today is $4.94 as on at the close of the market. CNS Pharmaceuticals Inc. share today touched a day high of $5.00 and a low of $4.66.

What is the 52 week high and 52 week low for CNS Pharmaceuticals Inc. share?

CNS Pharmaceuticals Inc. share touched a 52 week high of $12.36 on and a 52 week low of $1.90 on . CNS Pharmaceuticals Inc. stock price today i.e. is closed at $4.94,which is 60.03% down from its 52 week high and 160.00% up from its 52 week low.

What is CNS Pharmaceuticals Inc.'s market capitalisation today?

CNS Pharmaceuticals Inc. market capitalisation is $0.00T as on .

How to invest in CNS Pharmaceuticals Inc. Stock (CNSP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for CNS Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in CNS Pharmaceuticals Inc. Shares that will get you 0.3036 shares as per CNS Pharmaceuticals Inc. share price of $4.94 per share as on July 3, 2026 at 1:29 am IST.

What is the minimum amount required to buy CNS Pharmaceuticals Inc. Stock (CNSP) from India?

Indian investors can start investing in CNS Pharmaceuticals Inc. (CNSP) shares with as little as ₹95.39 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.90 in CNS Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on CNS Pharmaceuticals Inc. share’s latest price of $4.94 as on July 3, 2026 at 1:29 am IST, you will get 2.0243 shares of CNS Pharmaceuticals Inc.. Learn more about fractional shares .

What are the returns that CNS Pharmaceuticals Inc. has given to Indian investors in the last 5 years?

CNS Pharmaceuticals Inc. stock has given -100% share price returns and 26.88% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?